Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-10-006553
Filing Date
2010-02-16
Accepted
2010-02-16 15:09:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 doc1.htm SC 13G/A 62763
2 MISCELLANEOUS EXHIBITS misc1.htm EX-99.1 3368
  Complete submission text file 0001140361-10-006553.txt   68392
Mailing Address PO BOX 900 ZURICH V8 CH 8070
Business Address PO BOX 900 FHLS ZURICH V8 CH 8070 41 1 212 16 16
CREDIT SUISSE AG/ (Filed by) CIK: 0000824468 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81034 | Film No.: 10606856
SIC: 2834 Pharmaceutical Preparations